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Abstract
Relapsing fever, caused by spirochaetes belonging to the genus Borrelia, was once the cause of worldwide epidemic disease. This was
largely through infection with the louse-borne form of the disease, caused by Borrelia recurrentis (louse-borne relapsing fever (LBRF)).
During the last century, we have witnessed the demise of this infection, largely owing to improved standards of living and the intro-
duction of the insecticide DDT, resulting in a reduction in the incidence of the body louse, the vector for relapsing fever. In areas of
extreme poverty this disease persists, causing a signiﬁcant burden of disease. It is now looking probable that this infection is caused by
a louse-adapted variant of Borrelia duttonii, transmitted by Ornithodoros moubata ‘soft’ ticks in East Africa. Like LBRF, infection still causes
impact, particularly affecting young children and pregnant women. Over recent years, the true burden of relapsing fever caused by infec-
tion with the closely related Borrelia crocidurae, transmitted by Ornithodoros sonrai ticks, has only just begun to emerge. Here, the current
state of knowledge concerning relapsing fever in Africa is reviewed.
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Background
In countries such as Ethiopia, infestation with clothing lice
remains commonplace; for example, 66.8% of schoolchildren
were found to be infested in a study by Tesfayohannes [1].
Transmission may be further increased through habitual crush-
ing of lice between ﬁngers, thus liberating spirochaete-infected
material (Fig. 1). The tick-borne form of the disease persists in
endemic foci around the world (tick-borne relapsing fever
(TBRF)). Despite the general reduction worldwide, the disease
remains a signiﬁcant burden in several African nations. Indeed,
TBRF has been reported to be the most common bacterial
infection in Senegal [2], and is usually listed among the top ten
causes of mortality in children under 5 years of age in Tanzania
[3]. Here, it is responsible for alarming perinatal mortality,
with rates of 463/1000 in endemic regions [3,4]. In Ethiopia,
louse-borne relapsing fever (LBRF) is, again, among the top ten
reasons for hospital admission (countrywide), is associated
with signiﬁcant morbidity and mortality (Table 1), and is largely
perpetuated by poverty. Although a decline has been reported
in some regions [5], in others, LBRF can account for 27% of
hospital admissions [6].
Traditional Concepts
Nomenclature has traditionally involved a combination of the
disease vector and the geographical region in which infection
was acquired. In Africa, relapsing fever has classically been
assumed to result from Borrelia crocidurae in the west and
Borrelia hispanica in the north, whereas the tick-borne Borrelia
duttonii and the louse-borne Borrelia recurrentis persist in the
east. These assumptions could not be tested in the absence
of diagnostic methods with discriminatory power sufﬁcient
to identify or type the causative spirochaetes.
All four agents result in relapsing fever; however, subtle
clinical differences have been correlated with infecting spe-
cies. This is particularly evident with epitasis among patients
with LBRF (Table 1), whereas B. duttonii results in a particu-
larly poor prognosis during pregnancy [4]. B. crocidurae and
B. hispanica account for high fever, frequent neurological
complications and up to nine recurrences over several
months, but mortality appears to be much lower with these
two species than with B. duttonii and B. recurrentis. In Senegal,
no deaths occurred among 521 patients from various areas,
and only one of 16 infections that arose in pregnant women
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provoked early delivery [2,7]. Among case reports of patients
hospitalized for TBRF in Dakar since 1934, only a single death
has been reported [8] among the several hundred patients
who were included in these studies [9–14].
LBRF reached epidemic proportions during the ﬁrst half of
the last century, devastating populations as it ravaged the globe.
In Africa, the most dramatic epidemics occurred after World
Wars I and II, when French and British colonial soldiers
returned to their countries. The ﬁrst epidemic, in West Africa,
lasted from 1921 to 1929, and was responsible for 60 000
deaths [15]. During World War II, 400 000 cases were
observed in Algeria, 400 000 in Tunisia, 180 000 in Morocco,
and 1 300 000 in Egypt [16–18]. In the following years, the epi-
demic reached at least 15 additional African countries, from
Senegal to Sudan. Associated mortality was high, resulting in the
documentation of this form of the disease as having greater
severity than its tick-borne counterparts. However, patients
rarely succumbed to more than four episodes of fever, whereas
more numerous, albeit less severe, febrile episodes followed
TBRF, with anything up to 13 relapses occurring [19]. Mortality
from the louse-borne form of the disease can be high, in excess
of 30% of untreated cases; however, with appropriate treat-
ment, this can be reduced to 2% to 6% [6,20] (Fig. 2). Shaving
the hair of cases, coupled with boiling of their clothes immedi-
ately after diagnosis, can reduce further transmission of infec-
tion. Treatment itself can be problematic, with up to 76% of
cases exhibiting a Jarisch–Herxheimer reaction, particularly
when spirochaete numbers are high [6]. The dogma that LBRF
shows seasonality, typically manifesting during the rainy season,
has been challenged by studies of infection in more rural set-
tings. Here, signiﬁcantly more infection is seen in the dry sea-
son, coinciding with the coffee-harvesting period, probably
associated with temporary migration of highlanders seeking
employment [20].
The characteristic gene conversion leading to multiphasic
antigenic variation of these spirochaetes is pivotal in the aeti-
ology of recurrent febrile episodes, and has attracted signiﬁ-
cant research interest over recent years. Indeed, it now
appears that antigenic variation is mediated through gene con-
version events at a unique telomeric expression site. This has
been shown to be on the 23-kb linear plasmid of B. recurrentis
[21] and a plasmid of equivalent size in B. duttonii [22]. Pivotal
to gene conversion events are an upstream homology
sequence proximal to the expression start codon and an ex-
tragenic downstream homology sequence through which
recombination cross-over events occur [19,23]. During anti-
genic switching, the expressed gene is displaced by an
achieved copies of variable antigen genes, usually residing on
the linear plasmids of these spirochaetes.
Epidemiological Investigations
Obtaining sound epidemiological information is challenging, in
part because of the dogma that all febrile episodes are a result
of malaria. Indeed, many cases of relapsing fever present as
‘treatment-resistant malaria’, as reported in studies from Togo,
where patients are often misdiagnosed as malaria cases
[24,25]. Malaria co-infection with relapsing fever has been
reported from Ethiopia and Tanzania [26]. Generally, only
LBRF is a reportable infection; however, the reported data are
likely to represent a vast underestimation of the true burden
of disease. Despite this, in Ethiopia, LBRF is listed in a recent
Ministry of Health report (2004) as the seventh most common
reason for hospital admission (2.5% of total; 3777 cases) and
the ﬁfth most common cause of death (0.9%; 42 cases). Fur-
thermore, epidemics of variable scales occurred during 2004
and 2005 in Oromia and southern regions of Ethiopia (2004
and 2005, Ministry of Health Reports).
Data concerning the prevalence of TBRF are difﬁcult
to obtain, with most estimates being made on the basis of
TABLE 1. Major presenting signs of LBRF among a cohort of
106 cases [6]
Clinical Signs Number (n=106) Percentage
Fever 106 100
Tachycardia 104 98
Headache 101 95.3
Myalgia 98 92.5
Arthralgia 98 92.5
Hepatosplenomegaly 71 67
Epistaxis 32 30.2
Peticheal rash 8 7.6
Other* 3 2.8
Jaundice 1 0.9
*Other symptoms included pneumonia; still-birth; and unconsciousness.
FIG. 1. Mother delousing her child in Ethiopia.
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sporadic localized studies. These, however, have suggested
that, in East Africa, the major burden of disease particularly
affects the young, the elderly, and pregnant women. Estimates
of impact during pregnancy are high, especially associated with
B. duttonii infection, with 6.4% of cases being reported among
hospital admissions of pregnant women, often associated with
adverse outcomes, in the Democratic Republic of Congo [27].
Studies from Tanzania have reported total pregnancy loss rates
of 475 per 1000 births in endemic areas, with 58% of those
infected during pregnancy having premature deliveries [28].
In West Africa, B. crocidurae, a zoonotic relapsing fever spi-
rochaete, predominates, and the human burden of infection
has been determined to be the most signiﬁcant of all bacterial
infections affecting the human population. In a study con-
ducted in a dispensary near Dakar (Fig. 3), Borrelia infections
were observed in 4% of children of between 5 and 14 years
of age, 2% of children between 2 and 4 years of age, and 0.5%
of children between birth and 1 year of age [29]. During pop-
ulation follow-up over 14 years in a Senegalese village, the
average incidence of TBRF was 11 per 100 person-years, and
all age groups were afﬂicted with a high incidence of the dis-
ease [2]. In some years, up to 25% of this community suffered
from the disease. In areas endemic for Ornithodoros sonrai in
Senegal, Mali, Mauritania, and The Gambia, between 2% and
70% of animal burrows are inhabited by this tick vector, and
an average of 31% of individual ticks are infected by B. crocidu-
rae (Fig. 4) [2,30,31]. Rodent burrows are found in almost all
households, with burrows opening inside bedrooms of both
traditional mud-built huts and houses with cement ﬂoors and
walls (Fig. 5). Transmission is mainly nocturnal, with ticks bit-
ing humans during their sleep. The bite is painless, and blood
meals last from a few minutes to half an hour. Principle reser-
voirs for this spirochaete include at least 11 species of wild
rodents and insectivores; the most important epidemiologi-
cally are the multimammate rats Mastomys erythroleucus and
Mastomys huberti, the Nile rat Arvicanthis niloticus, and the
giant Gambian rat Cricetomys gambianus [7,11,32].
B. hispanica TBRF is endemic to Morocco, Algeria, and
Tunisia, mainly occurring along the coast and among the Tell
FIG. 2. Clinical case of louse-borne relapsing fever.
FIG. 3. Relapsing fever investigations in Mali.
FIG. 4. Ornithodoros sonrai, the soft tick vector of Borrelia crocidurae
in West Africa.
FIG. 5. Rodent burrows in human dwellings being investigated for
the presence of Ornithodoros sonrai ticks.
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mountains. It is transmitted by Ornithodoros erraticus, which
inhabits the burrows of a number of rodents and other small
mammals [18]. In endemic regions of Morocco, up to 50% of
the rodent burrows are colonized by either O. erraticus or by
O. sonrai [33]. Exposure appears to correlate with sleeping in
the open, whereby contact is facilitated through proximity to
rodent burrows and their ticks. The incidence in humans is
poorly documented, but seems to be much lower than the
incidence in West Africa of B. crocidurae, probably because of
better quality of housing. Several cases are detected each year
as part of malaria surveillance programmes, but the true inci-
dence of the disease remains unknown.
On a more cautionary note, it must be remembered that
microscopy is primarily used for diagnosis, and is a technique
with low sensitivity that does not distinguish among infecting
species (Fig. 6). Consequently, assumptions as to the causative
species for relapsing fever are usually based on geographical
location and vectors. Vector competence studies were under-
taken during the 1950s; however, these were hampered by
the lack of cultivable strains and of diagnostic tools able to
discriminate among species. In addition, the sensitivity of
microscopy varies according to Borrelia species. The blood
density of spirochaetes of febrile patients is particularly low
for B. crocidurae and B. hispanica, with 95% of samples possess-
ing <200 Borrelia organisms per microlitre of blood, mostly
with <20/lL. Conversely, the spirochaete density for B. duttonii
is often ten times higher, and that for B. recurrentis is higher
still; this might, in part, explain the differences in severity of
the disease.
Despite the epidemic potential of the louse-borne form of
disease, adaptation to louse-borne transmission may represent
an evolutionary bottleneck, resulting in the recently observed
demise of LBRF. Indeed, it is now believed that disease per-
sists only in Ethiopia, occasionally spilling into neighbouring
countries, possibly in association with the recurrent famines
and drought affecting these areas. Vector transmission studies
from the 1950s suggested that LBRF retained its potential for
tick-borne transmission; however, this remains to be substan-
tiated in a natural setting. Intriguingly, recent phylogenetic
studies have shown identical intragenic spacer types in both
lice and ticks; however, further validation of these ﬁndings
through sequencing of other gene targets remains to be per-
formed [34].
Emerging Challenges to Conventional
Paradigms
The ﬁnding of overlapping genotypes between B. recurrentis
and B. duttonii, based on intragenic spacer typing, challenges
the dogma that these are separate species [35]. Indeed, com-
plete genomic sequencing provided further evidence that B. re-
currentis is a louse-adapted variant of B. duttonii [22]. It is
tempting to speculate that tick-borne ancestral strains may
exist where these diseases geographically overlap. Currently
used diagnostics would be unlikely to discriminate among
these infections. Furthermore, if LBRF were to be eliminated
through sustained delousing of the population (Fig. 1), what
would prevent a parallel evolutionary event?
Transmission of LBRF has, until recently, been considered
to necessitate the crushing of infected lice into skin abrasions,
thus facilitating contact of infected haemolymph from the
louse with its human host. This dogma has now been chal-
lenged through the ﬁndings of Houhamdi and Raoult, who
demonstrated that B. recurrentis could be detected in louse
feeding following experimental infection [36]. Excretion in
faeces continued over a prolonged period of the louse
lifespan, thus providing a more efﬁcient means of transmission,
through excretion of B. recurrentis, than transmission via
crushing of lice alone. This route has also been described for
the louse-borne Rickettsia prowazekii and Bartonella quintana
[36]. In agreement with earlier literature, there was not,
however, transmission from infected lice to their progeny,
unlike with infection in ticks.
East African relapsing fever has been considered to be a
disease of humans alone, with the arthropod vector serving
as a disease reservoir. Conversely, other relapsing fever
borreliae have a broader host range, typically involving small
mammals. By analogy with this, an extended vertebrate host
range for East African relapsing fever has been sought. As
the ticks reside in and close to human dwellings (Fig. 5), it
appeared reasonable to investigate other vertebrates living
within typical traditional housing. Preliminary investigations
of rats and chickens as alternative reservoirs of infectionFIG. 6. Laboratory diagnosis at a health clinic in Jimma, Ethiopia.
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failed to produce conclusive evidence of expansion of
infection beyond the human host, possibly because of small
study sample sizes (unpublished ﬁndings). More recently,
some evidence has been provided, with the ﬁnding of
B. duttonii DNA in chickens and swine living close to their
human owners [37]; however, no attempt was made to
demonstrate transmission competence from these hosts,
and this may merely reﬂect ‘accidental spill-over’ from
human infection.
Analysis of ticks from endemic regions of Tanzania has
revealed a surprising ﬁnding of another Borrelia species
[26,38]. These ﬁndings have been corroborated by other
groups investigating ticks from the same region [34]. Phylo-
genetic analysis suggested greater resemblance to relapsing
fever species present in the USA than to isolates from cases
of Old World relapsing fever. Despite their presence in ticks
collected from local dwellings and in some healthy children,
these Borrelia species have only rarely been detected in clini-
cal samples from symptomatic individuals [26,34]; thus, their
pathogenic potential remains to be established.
The characteristic gene conversion leading to multiphasic
antigenic variation of these spirochaetes is pivotal in the aeti-
ology of recurrent febrile episodes, and has attracted signiﬁ-
cant research interest over recent years [19,23]. It was held
that blood persistence on the part of these spirochaetes was
entirely a result of their ability to undergo multiphasic anti-
genic variation; however, it now appears that a combination
of factors, such as the ability to bind factor H and factor -
H-like proteins, among other mechanisms, collectively assist
prolonged survival within the blood [39–41].
Post-genomic Insights into African
Relapsing fever
The recent publication of full genome sequences for B. recur-
rentis and B. duttonii relapsing fever spriochaetes has provided
opportunities to gain insights into the relationship between
these organisms, with B. recurrentis appearing as a louse-
borne derivative of B. duttonii [22]. Furthermore, several
intriguing features were noted for B. recurrentis, such as the
apparent truncation of recA, required for DNA repair;
similarly, mutS and smf, which work in conjunction with recA,
appeared to be non-functional, possibly hastening evolution
in this spirochaete. The absence of any unique features
within B. recurrentis that were not already present in B. dutto-
nii strongly supports its ancestral lineage from within B. dutto-
nii. Furthermore, the reduced numbers of variable membrane
protein genes detected within B. recurrentis, as compared
with its tick-borne counterpart, is in concordance with
clinical observations of fewer relapses among patients with
LBRF.
Full genomic sequencing has also enabled comparison of
these relapsing fever spirochaetes with the phylogenetically
related Lyme borreliosis spirochaetes over a total of 773
parologous chromosomal genes [22]. This revealed signiﬁcant
conservation of not only gene content, but also localization.
Only 13 genes were speciﬁc to Lyme-associated spirochae-
tes, whereas 17 were unique to the relapsing fever borreliae.
This is likely to form the genetic basis for the cross-reactivity
frequently observed in serological assays (excluding the GlpQ
assay mentioned below). Signiﬁcant divergence became
apparent when the plasmid contents of these spirochaetes
were compared [22].
We have explored the relationship among these spiro-
chaetes circulating in both Tanzania and Ethiopia by sequenc-
ing an intragenic spacer region [34]. Previously reported
groupings among these species described for cultivated spiro-
chaetes and those detected among arthropod vectors were
conﬁrmed using 123 sera from patients from Ethiopia and
Tanzania (unpublished observations). Similarly, the geographi-
cal demarcation of these spirochaetes was called into ques-
tion, with the ﬁnding of intragenic spacer region types
resembling B. crocidurae normally found in West Africa.
It has been hypothesized that full genomic sequencing of
two similar strains, one louse-borne and the other tick-borne,
might disclose the basis of louse adaptation as opposed to
tick-borne transmission. At this stage, the genetic basis for
vectorial speciﬁcity remains elusive. The basis of vector speci-
ﬁcity has fascinated spirochaetologists for many years [42].
Along parallel lines, it was anticipated that the apparent
greater severity of LBRF than of its tick-borne counterpart
might be explained by the results of full genomic sequencing.
Currently, it is difﬁcult to extract such information from
these sequences to determine the factors governing differen-
tial virulence; however, signiﬁcant reduction of variable mem-
brane protein genes is evident for B. recurrentis, as compared
to their tick-borne counterparts, with only one variable
membrane protein gene every 18 kb and one every 9.5 kb,
respectively, suggesting a reductive evolutionary path [22].
The high numbers of pseudogenes further support this the-
ory of evolutionary decay [22].
Future Perspectives
Arguably, the most signiﬁcant area for development in order
to understand African relapsing fever is improved detection
and typing of this spirochaete. Currently used microscopy-
based diagnostics could be improved in terms of sensitivity
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through concentration of the pathogen by light centrifugation,
to assist visualization of spirochaetes. Diagnosis is too fre-
quently missed through erroneous labelling of these febrile
patients as malaria cases, leading to the assumption that the
disease is a microbiological curiosity.
Increasing levels of business travel and tourism to destina-
tions such as Africa have been associated with subsequent
infection, often manifesting once the travellers are back in
their country of residence [43,44]. Reliance upon automated
diagnostics can present subsequent challenges for detection of
such cases. Serological methods for diagnosis have been devel-
oped, based on the GlpQ gene product, which is present in
relapsing fever spirochaetes, but absent in their close relatives,
the Lyme borreliosis spirochaetes [45].
Our understanding of the biology of these organisms is still
in its infancy. Persistence within the blood of an infected
patient is an essential prerequisite for successful transmission
to uninfected arthropod vectors. Whether antigenic variation
and currently disclosed pathophysiological interactions are suf-
ﬁcient alone to sustain the numbers of spirochaetes in the
blood needed to infect, for example, a louse remains to be
tested. It is similarly plausible that, as with American relapsing
fever, variable membrane protein expression may inﬂuence
tissue tropisms of these spirochaetes. However, unlike for
their American counterparts, animal models have proven difﬁ-
cult to establish, or even refractory to infection, as in the case
of B. recurrentis, thus making investigation of host–microbial
interactions challenging.
Phenomena such as ‘rosetting’ have been described for
these spirochaetes [46,47], originally hypothesized to be an
additional means of host evasion; however, more recent
investigations have suggested that spirochaetes may be
harvesting essential hypoxanthine purine metabolites from red
blood cells, for which the purA, purB and hpt genes are essen-
tial [48,49]. This trait has been described for both
B. crocidurae and B. duttonii, but not for B. recurrentis.
In summary, our understanding of African relapsing fever
spirochaetes is increasing (Fig. 7). The causative borreliae have
shown marked changes in their distributions and prevalence,
but they remain signiﬁcant and largely ignored infections on a
global level. Improved education and awareness of these infec-
tions, coupled with better detection and typing of the spiro-
chaetes, are essential if we are to manage relapsing fever
effectively. Although control of those species with animal res-
ervoirs is more challenging, infections with those species pre-
valent in East Africa could be reduced through prevention of
louse infestations and reduction of the exposure to tick vec-
tors of the disease.
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